A New Combination Therapy for HER2-Positive Metastatic Breast Cancer
The recent FDA approval of the drug Tukysa (tucatinib) for use with the chemotherapeutic agents trastuzumab and capecitabine...
Individuals who are inclined to take risks are more likely to make decisions that lead to innovation, a key factor that companies should consider as they seek to jumpstart research and development — and economic growth — in the wake of the COVID-19 virus.
New CMS rules and waivers expanding the use of telemedicine in response to the COVID-19 pandemic have left providers with questions about coding and billing.
Direct primary care (DPC) offers physicians and patients an alternative to fee-for-service care involving third-party payers. Two physicians who have been immersed in DPC for years say it has allowed them to get back to the basics of medicine — and that patients’ response proves it is a force to be reckoned with.
An FDA-approved drug cocktail may provide improvement for many patients with this common hereditary disease.